@JonRob08 Yes! Especially for mothers/sisters/daughters who for a lifetime have viewed hemophilia through the lens of the impact on sons/brothers/fathers, it can take exactly the right moment to truly hear and consider the question with respect to themselves. Every time, keep asking.
Kicking off #VWDConnect2023 National #severeVWD conference! Dr Chris Walsh introduces Dr Bob Montgomery, “dean and wizard of #VWF” 🩸🧙♂️🧪🔬🧬of @Versiti @BloodResearchWI, discussing with Dr Jordan Shavit @Clot1 the history and future. @ConnectVwd #hematologyGCs @pamchristophers
VBRI investigator Juliana Perez Botero @JuliPerezBot published in Clinical Case Reports: More than just mild thrombocytopenia: Clinical clues in the diagnosis of germline predisposition to malignancy from a rare ETV6 variant https://t.co/mxbcrBC3hX
@J9_Austin @laurahercher And so ironically, just last night I explained the jam jar to my own daughter. How many #genechat benefit from @J9_Austin research & brilliance not only in our workplace but with friends/fam too? Full circle from your start J9: GCs helping those we ❤️w psychiatric conditions. 🙏
@J9_Austin @laurahercher Oh @J9_Austin, my heart breaks to read this & feel the weight of this truth. (here I am thinking 🇨🇦 had distribution of healthcare figured out) You know your mentorship profoundly impacted me. Still does. The world is & will continue to be a better place for your work. Hold fast
Very excited to have this work out and a big thanks to @ksamocha and the rest of the gnomAD team for getting this over the finish line. I was very surprised to discover how uncommon it is to see two rare variants in most genes - learn something new everyday!
Pierce #EADAD on Gene Therapy in 2023. No ability to re-dose or alter a low expression, can not predict who will get a good expression or no expression or who will require steroids. Safety unknowns. Informed decision making.. 1/2
First #GeneTherapy for #Hemophilia B approved in the US today.
Stable expression beyond 12(!) years in the earliest programs.
Price tag of $3.5 million may seem high but annual FIX replacement averages >$600k annually.
Important day in the history of #haemophilia treatment. Today the first ever gene therapy for #hemophilia B has been approved by the FDA in the US. So now we have approved gene therapy for hemophilia A in Europe and hemophilia B in the US. https://t.co/J6fY49wbL9
D2-50 FREESTYLE: After just missing the podium last year in 8th place, Lucy Art, a Brown Deer/USM senior, comes back to win the 2022 State Title with a time of 23.37! 🥇
🥈 Anne Dickinson, @wfbsports freshman -23.52
🥉 Sophie Reed, @Crusaders_ATH senior - 23.72
#wiaaswimdive
Check out publication by @pamchristophers and colleages in @RPTHjournal: Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure https://t.co/q8mfkZyTPp
Khair #EHC2022 on shared decision making. She correctly states that this should be a process over several months, especially as we consider Gene Therapy which is an irreversible decision 1/
Calling any coag folks out there!!! Medical College of Wisconsin - Assistant Professor - Pediatric Hematology - Milwaukee WI 53201 https://t.co/WSHIHUxqge